Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up

Breast Cancer Research and Treatment

Volumn 49, Issue 1, 1998, Pages 27-33

  Landys, K ^a   Persson, S ^a   Kovarik J ^b   Hultborn, R ^a   Holmberg, E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Bone marrow micrometastases; Breast cancer; Monoclonal antibodies; Prognosis

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BONE MARROW BIOPSY; BONE METASTASIS; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILIAC CREST; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031867454     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005980919916     Document Type: Article

References (37)

1. Ridell B, Landys K: Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest. Cancer 44: 1782-1788, 1979
2. Nemeto T, Vana J, Bedwani RN: Management and survival of female breast cancer. Cancer 45: 2917-2924, 1980
3. Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer: hormonal, cytotoxic, or immune therapy. Lancet 339: 1-15, 75-85, 1992
4. Galasko CB: Anatomy and pathways of sekeletal metastases. In: Weiss L, Gilberg HA (eds) Bone Metastasis. Hall. Boston, 1981, pp 49-63
5. DiStefano A, Tachima CK, Yap HY, Hortobagyi GN: Bone marrow metastases without cortical bone involvement in breast cancer patients. Cancer 44: 196-198, 1979
6. Ingle JN, Tormey D, Tan HK: The bone marrow examination in breast cancer. Diagnostic considerations and clinical usefulness. Cancer 41: 670-674, 1987
7. Mansi JL, Easton D, Berger U, Gazet JC, Ford HT, Dearnaley D, Coombes RC: Bone marrow micrometastases in primary breast cancer. Prognostic significance after 6 year follow-up. Eur J Cancer 27(12): 1552-1555, 1991
8. Funke J, Fries S, Jauch KW: Detection of tumor cells in bone marrow: A deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase. Chirurg 62(11): 805-809, 1991
9. Menard S, Squicciarini P, Luini A, Sacchini V, Rovini D, Tagliabue E, Veronesi P, Salvadori B, Veronesi U, Colnaghi MI: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features. Br J Cancer 69(6): 1126-1129, 1994
10. Merkle E, Henke A, Bahr I, Buhner M, Lang N: Tumor cell detection in bone marrow of primary breast cancer patients (Meeting abstract). 18th Int Congress of Chemotherapy. June 27-July 2, 1993, Stockholm, Sweden, p322, 1993
11. Redding WH, Monaghan P, Imrie SF, Ormerod MG, Gazet J-C, Coombes RC, Clink HMcD, Dearnaley DP, Sloane JP, Powles TJ: Detection of micrometastases in patients with primary breast cancer. Lancet 2: 1271-1274, 1983
12. Diel IJ, Kaufmann M, Foerner R, Costa SD, Kaul S, Bastert G: Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 10: 1534-1539, 1992
13. Harbeck N, Untch M, Pache L, Eiermann W: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up. Br J Cancer 69: 566-571, 1994
14. TNM-classification of malignant tumours. Union Internationale Contre le Cancer, Geneva, 1972
15. Landys K: Role of bone and marrow biopsy in monitoring metastasis. In: Stoll BA, Parbhoo S (eds) Bone Metastasis Monitoring and Treatment. Raven Press, New York, 1983, p 153
16. Lauerová L, Kovarik J, Bártek J, Rejthar A, Vojtsek B: Novel monoclonal antibodies defining epitopes of human cytokeratin molecule. Hybridoma 7: 495-503, 1989
17. Bártek J, Dubran J, Hallowes RC, Taylor-Papadimitriou J: A subclass of luminal epithelial cells in the human mammary gland defined by antibodies to cytokeratins. J Cell Sci 75: 17-33, 1985
18. Cordell J, Richardson TC, Pulford KAF, Ghosh AK, Gatter KC, Heyderman E, Mason DY: Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 52: 347-354, 1985
19. Viac J, Reano A, Brochier J, Staquet MJ, Thivolet J: Reactivity pattern of a monoclonal anti-keratin antibody (KL1). J Invest Dermatol 81: 351-354, 1983
20. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT: Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J Cell Biol 95: 580-588, 1982
21. Fisher RA: The logic of inductive inference. J Royal Stat Soc, Series A 98: 39-54, 1935
22. Kaplan EL, Meier P: Non-parametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481, 1958
23. Dearnaley DP, Sloane JP, Imrie S, Coombes RC, Ormerod MG, Lumley H, Jones M, Neville AM: Detection fo isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med 76: 339-364, 1983
24. Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14(6): 1868-1876, 1996
25. Kirk SJ, Cooper GG, Hoper M, Watt PCH, Roy AD, Odling-Smee W: The prognostic significance of marrow micrometastases in women with early breast cancer. Eur J Surg Oncol 16: 481-485, 1990
26. Courtemanche DJ, Worth AJ, Coupland RW, Rowell JL, MacFarlane JK: Monoclonal antibody LICR-LON-M8 does not predict the outcome of operable breast cancer. Can J Surg 34(1): 21-26, 1991
27. Cote RJ, Rosen PP, Lesen ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9(10): 1749-1756, 1991
28. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR, Riethmuller G: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85 (17): 1419-1424, 1993
29. Pantel K, Felber E, Schlimok G: Detection and characterization of residual disease in breast cancer. J Hematother 3(4): 315-322, 1994
30. Cartagena N Jr, Susters S, Cabello-Inchausti B: Artifactual distortion of cells simulating small cell carcinoma in the bone marrow. Ann Clin Lab Sci 23(2): 130-136, 1993
31. Mansi JL, Berger U, McDonell T, Pople A, Rayter Z, Gazet JC, Coombes RC: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 74: 445-449, 1989
32. Schlimok G, Riethmuller G: Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1(3): 207-215, 1990
33. Ginsbourg M, Musset M, Misset JL, Mathé G: Relationship between proliferative activity of bone marrow micrometastases and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancer. Biomed & Pharmacother 40: 388-391, 1986
34. Emerman JT, Stingl J, Petersen A, Shiall EJ, Eaves CJ: Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells. Breast Cancer Res Treat 41: 147-159, 1996
35. Kvalheim G: Detection of occult tumour cells in bone marrow and blood in breast cancer patients. Methods and clinical significance. Acta Oncol Suppl 8: 13-18, 1997
36. Ginsbourg M, Musset M, Misset JL, Genty O, Mathé S: Simultaneous detection in the bone marrow of mammary cancer metastatic cells and of their labelling index as respective markers of the residual minimum submacroscopic disease and its proliferative condition. Biomed Pharmacother 40: 386-388, 1986
37. Mathieu M-CH, Friedman S, Bosq J, Aillou B, Spielmann M, Travagli J-P, Contesso G: Immunohistochemical staging of bone marrow biopsies for detection of occult metastasis in breast cancer. Breast Cancer Res Treat 15: 21-26, 1990